aTYR PHARMA INC (ATYR) Stock Profile — Insider Trades & Financials

Revenue$0

Net Income-$14.0M

EPS$-0.66

Market Cap$78.0M

Price Performance

Historical data including institutional events

Loading price data...

Company Profile

Sanjay S Shukla

CEO & Executive Director

aTyr Pharma is a public biotherapeutics company that is focused on researching the extracellular functionality and signaling pathways of tRNA synthetases.

Founded: 2005
Employees: 55
Headquarters: SAN DIEGO, CA, United States
Website: www.atyrpharma.com

Peer ComparisonRevenue ($B)

▾

⚡

Core Efficiency

ROE?

-20.69%

ROA?

-15.01%

📊

Profitability Ratios

Current Ratio?

5.30

Loading comparison...

Earnings Calendar

Filing history and next expected filing date

Next Expected Filing

Aug 12, 2026 (in 127 days)

Annual Report (10-K) — Based on filing pattern

Aug 12, 2026

Predicted10-K

Mar 5, 2026

10-KQ4 20253d after period end

Mar 5, 2026

10-KFY 202564d after period end

Nov 6, 2025

10-QQ3 20256d after period end

Aug 7, 2025

10-QQ2 20256d after period end

May 7, 2025

10-QQ1 20255d after period end

Mar 13, 2025

10-KQ4 20246d after period end

Mar 13, 2025

10-KFY 202572d after period end

Nov 7, 2024

10-QQ3 20242d after period end

Loading company sections...

aTYR PHARMA INC

Price Performance

Company Profile

Core Efficiency

Profitability Ratios

Earnings Calendar

Core Efficiency

Profitability Ratios

Earnings Calendar

Data Freshness